Tarsus Pharmaceuticals (TARS) Interest Coverage Ratio (2022 - 2025)
Historic Interest Coverage Ratio for Tarsus Pharmaceuticals (TARS) over the last 4 years, with Q3 2025 value amounting to 6.41.
- Tarsus Pharmaceuticals' Interest Coverage Ratio rose 3775.19% to 6.41 in Q3 2025 from the same period last year, while for Sep 2025 it was 9.68, marking a year-over-year increase of 5508.24%. This contributed to the annual value of 15.36 for FY2024, which is 6409.69% up from last year.
- Per Tarsus Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at 6.41 for Q3 2025, which was up 3775.19% from 9.9 recorded in Q2 2025.
- Over the past 5 years, Tarsus Pharmaceuticals' Interest Coverage Ratio peaked at 6.41 during Q3 2025, and registered a low of 61.78 during Q1 2022.
- Moreover, its 4-year median value for Interest Coverage Ratio was 21.76 (2022), whereas its average is 26.79.
- As far as peak fluctuations go, Tarsus Pharmaceuticals' Interest Coverage Ratio crashed by 31936.28% in 2023, and later skyrocketed by 7842.96% in 2024.
- Tarsus Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 21.76 in 2022, then tumbled by 106.5% to 44.94 in 2023, then soared by 76.5% to 10.56 in 2024, then skyrocketed by 39.35% to 6.41 in 2025.
- Its Interest Coverage Ratio stands at 6.41 for Q3 2025, versus 9.9 for Q2 2025 and 11.88 for Q1 2025.